Prolactin dynamics and tumor size in the prediction of surgical outcome for prolactinoma

D. Gordon, A. Richards, Ross Bullock

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Citations (Scopus)

Abstract

Each of 62 females were studied for a period of between two and 72 months (mean 36 months) following the removal of a prolactinoma by transphenoidal pituitary surgery. Our aims were to define the relationships between pre- and post-operative features, the operative findings and the functional outcome. Pre-operative serum prolactin (PRL) concentrations correlated with tumor diameter (r = 0.55, p < 0.001). Following surgery two groups of patients were identified: Group 1, 46 spontaneously and regularly menstruating patients and Group 2, 16 patients with persistent amenorrhoea. The patients in Group 1 had significantly lower pre-operative and post-operative serum (PRL) concentrations (p < 0.02 and p < 0.001 respectively) and significantly greater PRL responses to thyrotrophin releasing hormone (TRH) and metoclopramide stimulation after surgery (p < 0.001). There was not a significant difference in tumor size between the groups. Forty-four (96 per cent) of the patients in Group 1 had normal post-operative serum PRL concentrations within one week of surgery. By comparison (p < 0.001) only 42 and 20 per cent respectively Group 1 patients who were tested had normal TRH and metoclopramide evoked PRL secretion following surgery. Return of regular menstruation was associated with cessation of galactorrhoea in 44 patients (96 per cent) and ovulation occurred in 37 of 38 menstruating patients for whom data are available. All patients with normal TRH and metoclopramide stimulation tests menstruated spontaneously. Nevertheless most patients who menstruated did so in spite of retaining suppressed PRL responses. Of 46 patients following to date whose serum PRL was normal one week after surgery, seven later were found to have an elevation of serum PRL outside the normal range but in only two has this been persistent. We suggest that a single measurement of serum PRL one week following transsphenoidal pituitary surgery for prolactinoma provides a good basis for deciding about the future management of patients who desire menstruation and pregnancy.

Original languageEnglish
Title of host publicationQuarterly Journal of Medicine
Pages141-151
Number of pages11
Volume54
Edition214
StatePublished - Jan 1 1985
Externally publishedYes

Fingerprint

Prolactinoma
Prolactin
Neoplasms
Metoclopramide
Thyrotropin
Serum
Menstruation
Hormones
Amenorrhea
Ovulation
Reference Values

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gordon, D., Richards, A., & Bullock, R. (1985). Prolactin dynamics and tumor size in the prediction of surgical outcome for prolactinoma. In Quarterly Journal of Medicine (214 ed., Vol. 54, pp. 141-151)

Prolactin dynamics and tumor size in the prediction of surgical outcome for prolactinoma. / Gordon, D.; Richards, A.; Bullock, Ross.

Quarterly Journal of Medicine. Vol. 54 214. ed. 1985. p. 141-151.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gordon, D, Richards, A & Bullock, R 1985, Prolactin dynamics and tumor size in the prediction of surgical outcome for prolactinoma. in Quarterly Journal of Medicine. 214 edn, vol. 54, pp. 141-151.
Gordon D, Richards A, Bullock R. Prolactin dynamics and tumor size in the prediction of surgical outcome for prolactinoma. In Quarterly Journal of Medicine. 214 ed. Vol. 54. 1985. p. 141-151
Gordon, D. ; Richards, A. ; Bullock, Ross. / Prolactin dynamics and tumor size in the prediction of surgical outcome for prolactinoma. Quarterly Journal of Medicine. Vol. 54 214. ed. 1985. pp. 141-151
@inbook{dd0436e8d9044e2c97ba32dee795bc4e,
title = "Prolactin dynamics and tumor size in the prediction of surgical outcome for prolactinoma",
abstract = "Each of 62 females were studied for a period of between two and 72 months (mean 36 months) following the removal of a prolactinoma by transphenoidal pituitary surgery. Our aims were to define the relationships between pre- and post-operative features, the operative findings and the functional outcome. Pre-operative serum prolactin (PRL) concentrations correlated with tumor diameter (r = 0.55, p < 0.001). Following surgery two groups of patients were identified: Group 1, 46 spontaneously and regularly menstruating patients and Group 2, 16 patients with persistent amenorrhoea. The patients in Group 1 had significantly lower pre-operative and post-operative serum (PRL) concentrations (p < 0.02 and p < 0.001 respectively) and significantly greater PRL responses to thyrotrophin releasing hormone (TRH) and metoclopramide stimulation after surgery (p < 0.001). There was not a significant difference in tumor size between the groups. Forty-four (96 per cent) of the patients in Group 1 had normal post-operative serum PRL concentrations within one week of surgery. By comparison (p < 0.001) only 42 and 20 per cent respectively Group 1 patients who were tested had normal TRH and metoclopramide evoked PRL secretion following surgery. Return of regular menstruation was associated with cessation of galactorrhoea in 44 patients (96 per cent) and ovulation occurred in 37 of 38 menstruating patients for whom data are available. All patients with normal TRH and metoclopramide stimulation tests menstruated spontaneously. Nevertheless most patients who menstruated did so in spite of retaining suppressed PRL responses. Of 46 patients following to date whose serum PRL was normal one week after surgery, seven later were found to have an elevation of serum PRL outside the normal range but in only two has this been persistent. We suggest that a single measurement of serum PRL one week following transsphenoidal pituitary surgery for prolactinoma provides a good basis for deciding about the future management of patients who desire menstruation and pregnancy.",
author = "D. Gordon and A. Richards and Ross Bullock",
year = "1985",
month = "1",
day = "1",
language = "English",
volume = "54",
pages = "141--151",
booktitle = "Quarterly Journal of Medicine",
edition = "214",

}

TY - CHAP

T1 - Prolactin dynamics and tumor size in the prediction of surgical outcome for prolactinoma

AU - Gordon, D.

AU - Richards, A.

AU - Bullock, Ross

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Each of 62 females were studied for a period of between two and 72 months (mean 36 months) following the removal of a prolactinoma by transphenoidal pituitary surgery. Our aims were to define the relationships between pre- and post-operative features, the operative findings and the functional outcome. Pre-operative serum prolactin (PRL) concentrations correlated with tumor diameter (r = 0.55, p < 0.001). Following surgery two groups of patients were identified: Group 1, 46 spontaneously and regularly menstruating patients and Group 2, 16 patients with persistent amenorrhoea. The patients in Group 1 had significantly lower pre-operative and post-operative serum (PRL) concentrations (p < 0.02 and p < 0.001 respectively) and significantly greater PRL responses to thyrotrophin releasing hormone (TRH) and metoclopramide stimulation after surgery (p < 0.001). There was not a significant difference in tumor size between the groups. Forty-four (96 per cent) of the patients in Group 1 had normal post-operative serum PRL concentrations within one week of surgery. By comparison (p < 0.001) only 42 and 20 per cent respectively Group 1 patients who were tested had normal TRH and metoclopramide evoked PRL secretion following surgery. Return of regular menstruation was associated with cessation of galactorrhoea in 44 patients (96 per cent) and ovulation occurred in 37 of 38 menstruating patients for whom data are available. All patients with normal TRH and metoclopramide stimulation tests menstruated spontaneously. Nevertheless most patients who menstruated did so in spite of retaining suppressed PRL responses. Of 46 patients following to date whose serum PRL was normal one week after surgery, seven later were found to have an elevation of serum PRL outside the normal range but in only two has this been persistent. We suggest that a single measurement of serum PRL one week following transsphenoidal pituitary surgery for prolactinoma provides a good basis for deciding about the future management of patients who desire menstruation and pregnancy.

AB - Each of 62 females were studied for a period of between two and 72 months (mean 36 months) following the removal of a prolactinoma by transphenoidal pituitary surgery. Our aims were to define the relationships between pre- and post-operative features, the operative findings and the functional outcome. Pre-operative serum prolactin (PRL) concentrations correlated with tumor diameter (r = 0.55, p < 0.001). Following surgery two groups of patients were identified: Group 1, 46 spontaneously and regularly menstruating patients and Group 2, 16 patients with persistent amenorrhoea. The patients in Group 1 had significantly lower pre-operative and post-operative serum (PRL) concentrations (p < 0.02 and p < 0.001 respectively) and significantly greater PRL responses to thyrotrophin releasing hormone (TRH) and metoclopramide stimulation after surgery (p < 0.001). There was not a significant difference in tumor size between the groups. Forty-four (96 per cent) of the patients in Group 1 had normal post-operative serum PRL concentrations within one week of surgery. By comparison (p < 0.001) only 42 and 20 per cent respectively Group 1 patients who were tested had normal TRH and metoclopramide evoked PRL secretion following surgery. Return of regular menstruation was associated with cessation of galactorrhoea in 44 patients (96 per cent) and ovulation occurred in 37 of 38 menstruating patients for whom data are available. All patients with normal TRH and metoclopramide stimulation tests menstruated spontaneously. Nevertheless most patients who menstruated did so in spite of retaining suppressed PRL responses. Of 46 patients following to date whose serum PRL was normal one week after surgery, seven later were found to have an elevation of serum PRL outside the normal range but in only two has this been persistent. We suggest that a single measurement of serum PRL one week following transsphenoidal pituitary surgery for prolactinoma provides a good basis for deciding about the future management of patients who desire menstruation and pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=0021895536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021895536&partnerID=8YFLogxK

M3 - Chapter

VL - 54

SP - 141

EP - 151

BT - Quarterly Journal of Medicine

ER -